Skip to main content
Equibles

Swiss National Bank

Bank

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1582202 ZURICH, V8
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,849,187
+$333,771 QoQ
Shares Held
155,100
+20.6% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 215 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. VRDN ranks #93 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,849,187 155,100
2026-03-31 $2,515,416 128,600
2025-12-31 $4,002,032 128,600
2025-09-30 $2,388,906 110,700
2025-06-30 $1,522,422 108,900
2025-03-31 $1,449,100 107,500
2024-12-31 $2,158,542 112,600
2024-09-30 $2,459,275 108,100
2024-06-30 $1,204,726 92,600
2024-03-31 $1,451,579 82,900
2023-12-31 $1,463,616 67,200
2023-09-30 $1,018,576 66,400
2023-06-30 $1,444,053 60,700
2023-03-31 $1,656,144 65,100
2022-12-31 $2,108,962 72,200
2022-09-30 $1,382,374 67,400
2022-06-30 $424,619 36,700